transplant-related infectious disease
clinical infectious disease
Blyth D, Lee I, Sims KD, Gasink LB, Barton TD: Risk factors and clinical outcomes of cytomegalovirus disease occurring more than 1 year post solid organ transplantation. Transpl Infect Dis 14(2): 149-55, Apr 2012.
Garland JM, Rusk MH, Hudson PH, Barton TD, Cohn JE: Design and implementation of a novel resident educational experience utilizing the electronic medical record in a refugee health clinic
Association of Program Directors in Internal Medicine Spring 2011 Meeting, Las Vegas, NV
April 2011 Notes: Poster presentation.
Mascitti KB, Gerber JS, Zaoutis TE, Barton TD, Lautenbach E: Preferred treatment and prevention strategies for recurrent community-associated methicillin-resistant staphylococcus aureus skin and soft-tissue infections: a survey of adult and pediatric providers. American Journal of Infection Control 38(4): 324-8, May 2010.
Longworth SA, Vinnard C, Lee I, Barton T: Risk factors for nontuberculous mycobacterial(NTM)infections in heart and lung transplant recipients. International Society for Heart and Lung Transplantation 30th Anniversary Meeting and Scientific Sessions, Chicago, IL April 2010 Notes: Poster presentation.
Mascitti KB, Gerber JS, Zaoutis TE, Barton TD, Lautenbach E: Preferred treatment and prevention strategies for recurrent community-associated methicillin-resistant staphylococcus aureus skin and soft-tissue Infections: a survey of adult and pediatric providers. 20th Annual Meeting of the Society for Healthcare Epidemiology of America (SHEA), Fifth Decennial International Conference on Healthcare-Associated Infections, Atlanta, GA March 2010 Notes: Poster presentation.
Vinnard C, Barton TD, Jerud E, Blumberg EA: A report of HHV-6 associated encephalitis in a solid organ transplant recipient and a review of previously published cases
Liver Transpl 15(10): 1242-6, Oct 2009.
Shiley KT, Gasink LB, Barton TD, Pfeiffenberger P, Olthoff KM, Blumberg EA: Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis. Liver Transpl 15(8): 963-7, Aug 2009.
Blyth D, Lee I, Sims K, Barton TD: CMV viremia in patients more than 1 year post-solid organ transplantation
9th American Transplant Congress, Boston, MA June 2009.
Shiley KT, Gasink LB, Barton TD: Increased incidence of late-onset CMV disease in high-risk liver transplant recipients receiving valganciclovir prophylaxis 8th American Transplant Congress Boston, MA June 2008 Notes: Poster presentation.
Linkin DR, Fishman NO, Landis JR, Barton TD, Gluckman S, Kostman J, Metlay JP: Effect of communication errors during calls to an antimicrobial stewardship program
Infect Control Hosp Epidemiol 28(12): 1374-81, Dec 2007
back to top
Last updated: 11/19/2013
The Trustees of the University of Pennsylvania